0001562180-20-004689.txt : 20200625
0001562180-20-004689.hdr.sgml : 20200625
20200625164541
ACCESSION NUMBER: 0001562180-20-004689
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200623
FILED AS OF DATE: 20200625
DATE AS OF CHANGE: 20200625
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KIRITSY CHRISTOPHER P
CENTRAL INDEX KEY: 0001261156
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37471
FILM NUMBER: 20989839
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PIERIS PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001583648
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 300784346
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 255 STATE STREET
STREET 2: 9TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02109
BUSINESS PHONE: 857-246-8998
MAIL ADDRESS:
STREET 1: 255 STATE STREET
STREET 2: 9TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02109
FORMER COMPANY:
FORMER CONFORMED NAME: Marika Inc.
DATE OF NAME CHANGE: 20130805
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2020-06-23
false
0001583648
PIERIS PHARMACEUTICALS, INC.
PIRS
0001261156
KIRITSY CHRISTOPHER P
C/O PIERIS PHARMACEUTICALS, INC.
255 STATE STREET, 9TH FLOOR
BOSTON
MA
02109
true
false
false
false
Stock Option (right to buy)
3.27
2020-06-23
4
A
false
40000.00
0.00
A
2030-01-23
Common Stock
40000.00
40000.00
D
The stock option will vest as to 100% of the underlying shares on June 23, 2021, subject to the Reporting Person's continued service as a director through the vesting date.
/s/ Marc D. Mantell, Attorney-in-fact
2020-06-25